GlassScriptPhysician profile
Simon Rainer Fraser
NPI 1659764280
$25,327.20
in general payments reported to CMS, 2019-2025
25 companies · $11K in 2025
The $11K reported for 2025 was more than what 91% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $4,651 · 2021: $1,564 · 2022: $4,342 · 2023: $1,079 · 2024: $2,367 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,280 · Consulting Fee: $3,300 · Travel and Lodging: $2,853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,280.12 |
| Consulting Fee | $3,300.00 |
| Travel and Lodging | $2,852.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,977.76 | 2021-2025 | Endurant Iis, Valiant Captivia, Heli-Fx Endoanchor System |
| Medtronic Vascular, INC. | $4,758.40 | 2019-2020 | |
| Shockwave Medical, INC | $4,302.40 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $2,303.72 | 2021-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Excluder Iliac Branch Endoprosthesis |
| Silk Road Medical, INC. | $1,706.89 | 2022 | |
| Cook Medical LLC | $1,677.64 | 2020-2025 | Zenith, Cook, Zenith Spiral-Z |
| Endologix LLC | $892.30 | 2024-2025 | Alto Abdominal Stent Graft System, Endocross Device, Torus Stent Graft System |
| Abbott Laboratories | $273.36 | 2021-2022 | |
| Inari Medical, INC. | $261.85 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kerecis Limited | $251.06 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Bolton Medical INC | $180.51 | 2021 | |
| Innovation Technologies INC | $145.30 | 2025 | Irrisept |
| Penumbra, INC. | $135.65 | 2024 | Indigo System |
| Davol INC. | $110.53 | 2019 | |
| Medical Device Business Services, INC. | $89.42 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prytime Medical Devices, INC. | $43.23 | 2023 | Er-Reboa Plus |
| Lemaitre Vascular, INC. | $38.26 | 2023 | Restoreflow, Anastoclip Gc 8cm (Medium), Artegraft Vascular Graft |
| Boston Scientific Corporation | $37.34 | 2023-2025 | Eluvia |
| Philips North America LLC | $37.19 | 2023 | |
| Thrombolex, INC. | $26.58 | 2025 | Bashir Endovascular Catheter |
| Bard Peripheral Vascular, INC. | $22.29 | 2022 | |
| Cagent Vascular INC | $18.58 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.33 | 2023 | Xarelto |
| Smith+Nephew, INC. | $15.95 | 2023 | Pico 14 |
| Cardiovascular Systems INC. | $3.66 | 2023 | Diamondback Peripheral |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Fraser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.